Abstract: The present invention relates to a composition for preventing or treating liver fibrosis, which includes a Sanguisorba officinalis extract as an active ingredient, and more particularly, to a composition for preventing or treating liver fibrosis, which includes a Sanguisorba officinalis extract or ziyuglycoside. The Sanguisorba officinalis extract or ziyuglycoside of the present invention inhibits liver fibrosis and the expression of a liver fibrosis-related gene, so it may be effectively used in the composition for preventing or treating liver fibrosis.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a super pink (Dianthus superbus L.) extract as an active ingredient.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a Musan box (Sphallerocarpus gracilis) extract or a fraction thereof as an active ingredient.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a Thalictrum (Thalictrum squarrosum steph) extract or a fraction thereof as an active ingredient.

Abstract: Provided are a composition including Stellera chamaejasme extract for treating wound, a method of treating wound of a subject, a cosmetic composition for wound improving, skin wrinkle improving, or skin anti-aging, and a method of cosmeticizing for wound improving, skin wrinkle improving, or skin anti-aging.

Abstract: Provided are a pharmaceutical composition including a Crepidiastrum denticulatum extract as an active ingredient; and a method for preventing or treating ischemia-reperfusion injury in a subject by using a food composition or the pharmaceutical composition.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a Musan box (Sphallerocarpus gracilis) extract or a fraction thereof as an active ingredient.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a super pink (Dianthus superbus L.) extract as an active ingredient.

Abstract: Disclosed is a composition for ameliorating, preventing or treating an autoimmune skin disease, containing a Thalictrum (Thalictrum squarrosum steph) extract or a fraction thereof as an active ingredient.

Abstract: Provided are a method for preventing or treating obesity by using a composition including an inhibitor of expression of the Hoga1 gene or an inhibitor of activity of the Hoga1 protein as an active ingredient, and a method of screening a preventive or therapeutic agent for obesity by using the composition.

Abstract: Provided are a pharmaceutical composition including a Crepidiastrum denticulatum extract as an active ingredient; and a method for preventing or treating ischemia-reperfusion injury in a subject by using a food composition or the pharmaceutical composition.

Abstract: Provided are a method for preventing or treating obesity by using a composition including an inhibitor of expression of the Hoga1 gene or an inhibitor of activity of the Hoga1 protein as an active ingredient, and a method of screening a preventive or therapeutic agent for obesity by using the composition.

Abstract: Provided are a composition including Stellera chamaejasme extract for treating wound, a method of treating wound of a subject, a cosmetic composition for wound improving, skin wrinkle improving, or skin anti-aging, and a method of cosmeticizing for wound improving, skin wrinkle improving, or skin anti-aging.

Abstract: Provided are a pharmaceutical composition including a Crepidiastrum denticulatum extract as an active ingredient; and a method for preventing or treating ischemia-reperfusion injury in a subject by using a food composition or the pharmaceutical composition.

Abstract: Provided are a composition including Stellera chamaejasme extract for treating wound, a method of treating wound of a subject, a cosmetic composition for wound improving, skin wrinkle improving, or skin anti-aging, and a method of cosmeticizing for wound improving, skin wrinkle improving, or skin anti-aging.

Abstract: The present disclosure relates to an apparatus and a method for fabricating an antimicrobial hybrid material of a natural antimicrobial particle and a carbon nanomaterial, capable of fully utilizing the antimicrobial property of a natural antimicrobial material and a carbon nanomaterial by maximizing adsorption of the natural antimicrobial material on the carbon nanomaterial.

Abstract: The present invention relates to a method for the prevention and treatment of postmenopausal syndrome containing the step of administering a pharmaceutically effective dose of the Aceriphyllum rossii or its fractions to a subject. The present inventors confirmed that the Aceriphyllum rossii extract or its fractions of the invention prepared by using water, alcohol or a mixed solvent thereof could promote the expression of the promoter containing estrogen responsive element (ERE) and accelerated the growth of MCF-7, the human breast tissue originated cell line, suggesting that they had estrogen activity. The inventors further confirmed that the extract or its fractions of the invention had the effect of promoting osteocyte differentiation, so that they could be effectively used for the prevention and treatment of postmenopausal syndrome such as hot flush, osteoporosis and phlebothrombosis caused by estrogen deficiency.

Abstract: The present disclosure relates to an apparatus and a method for fabricating an antimicrobial hybrid material of a natural antimicrobial particle and a carbon nanomaterial, capable of fully utilizing the antimicrobial property of a natural antimicrobial material and a carbon nanomaterial by maximizing adsorption of the natural antimicrobial material on the carbon nanomaterial.

Abstract: The present invention relates to a pharmaceutical composition for the prevention and treatment of cancer comprising daurinol as an active ingredient, more precisely a pharmaceutical composition for the prevention and treatment of cancer comprising daurinol isolated from the medicinal plant of Mongolia, Haplophyllum dauricum or Haplophyllum cappadocicum, as an active ingredient. Daurinol can selectively block the S phase of cancer cell cycle to disturb the cycle and induce apoptosis stepwise, resulting in anticancer effect. Therefore, daurinol of the present invention can be used as a positive control chemical in the research and development field of cancer biology especially for cancer therapy and prevention. Daurinol also can be a promising candidate for a novel cell cycle blocker and a novel apoptosis inducer which could be effectively used for the prevention and treatment of cancer in the end.

Abstract: The present invention relates to a method for the prevention and treatment of postmenopausal syndrome containing the step of administering a pharmaceutically effective dose of the Aceriphyllum rossii or its fractions to a subject. The present inventors confirmed that the Aceriphyllum rossii extract or its fractions of the invention prepared by using water, alcohol or a mixed solvent thereof could promote the expression of the promoter containing estrogen responsive element (ERE) and accelerated the growth of MCF-7, the human breast tissue originated cell line, suggesting that they had estrogen activity. The inventors further confirmed that the extract or its fractions of the invention had the effect of promoting osteocyte differentiation, so that they could be effectively used for the prevention and treatment of postmenopausal syndrome such as hot flush, osteoporosis and phlebothrombosis caused by estrogen deficiency.